<DOC>
	<DOCNO>NCT00198510</DOCNO>
	<brief_summary>The purpose study determine intravitreal injection Vitrase ( ovine hyaluronidase ) clear vitreous hemorrhage</brief_summary>
	<brief_title>Safety Efficacy Study Vitrase Clearance Severe Vitreous Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Vitreous Hemorrhage</mesh_term>
	<criteria>Severe vitreous hemorrhage obscure visualization fundus indirect ophthalmoscopy , present &gt; /= 1 month history exam BCVA worse 20/200 time screen Corneal lenticular abnormality preclude fundus observation Ongoing ocular infection , inflammation history herpetic corneal lesion Current prior retinal detachment retinal tear break intraocular tumor More 1 severe vitreous hemorrhage within 6 month Previous vitrectomy reason Hemorrhage exclusively preretinal , old &amp; organize Prior Vitrase intravitreal injection either eye No light perception either eye time Known contraindication study medication Sickle cell disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>